Gaudium IVF IPO Allotment Status: Check on BSE, NSE, Bigshare

Gaudium IVF IPO allotment is expected on Feb 25, 2026, and the listing is tentatively lined up for Feb 27, 2026. The IPO saw a clear late push in subscription, ending Day 3 at 7.27x overall, led by strong NII demand.

In this blog, you’ll learn how to check your allotment status on BSE, NSE, and KFinTech, plus a quick read of the subscription trend, the latest GMP mood, and what it could mean for listing-day expectations.

Important Dates

• Allotment Date: Feb 25, 2026
• Refund Initiation: Feb 26, 2026
• Demat Credit: Feb 26, 2026
• Listing Date: Feb 27, 2026 (Tentative)

How to Check Gaudium IVF IPO Allotment Status?

Method 1: Check on BSE

• Open the BSE IPO allotment page: https://www.bseindia.com/investors/appli_check.aspx
• Choose “Equity” as the issue type.
• Select “Gaudium IVF & Women Health Ltd” from the dropdown list.
• Enter your application number or PAN, and the captcha code.
• Click “Search” to view whether shares have been allotted to you.

Method 2: Check on NSE

• Go to the NSE IPO allotment status page: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
• Click on “Equity & SME IPO bid details.”
• Select “Gaudium IVF & Women Health Ltd” from the issue name list.
• Enter your application number or PAN.
• Submit to see if you have received shares or not.​

Method 3: Check on Registrar (Bigshare)

• Visit Bigshare Services public issues page: https://www.bigshareonline.com/ipo_allotment.html
• Choose a server from the three given options.
• Select “Gaudium IVF & Women Health Ltd” from the dropdown.
• Choose an option from PAN, DP ID/Client ID, or Application Number.
• Click “Search” to view your detailed allotment status.

Gaudium IVF IPO Subscription Details

Source: Chittorgarh.com

• The trend shows a soft Day 1, a big jump by Day 2, and a strong close on Day 3, mainly driven by NII and improving QIB participation.
• With Retail at 7.6x and Total at 7.27x, allotment becomes more competitive, so the probability of full allotment is naturally lower.

Also Read: Gaudium IVF IPO Explained: 19 New Centres, High Margins, and Key Concerns

Gaudium IVF IPO GMP Update

Gaudium IVF IPO GMP cooled steadily from ₹8.5 (Feb 19) to ₹0 by the closing day (Feb 24), and it stayed at ₹0 on allotment day (Feb 25). This shift implied the expected listing gain moved from about 10.76% to 0.00%, suggesting sentiment turned cautious as the issue progressed.

Disclaimer: GMP is an unofficial, unregulated indicator, and it can change quickly, so treat it as a mood check, not a guarantee.

What’s Next After Allotment?

If shares are allotted

• Your allotment result will show on the status page (BSE/NSE/Bigshare) with the number of shares allotted.
• Shares are expected to be credited to your demat on Feb 26, 2026.
• If you applied for more shares than you got, the extra money is typically refunded or your UPI mandate is adjusted for the unallotted amount.
• Next, you can track the stock for listing on Feb 27, 2026 (tentative) and decide your plan based on your risk comfort.

If shares are not allotted

• Your refund (or UPI unblocking) is expected around Feb 26, 2026.
• You won’t receive any shares in demat if allotment is not done.
• You can still buy the stock after listing, if the price and business fit your plan.
• Oversubscription reduces the chances, even if your application is fully valid.

For detailed information about the IPO, visit Gaudium IVF’s official IPO page at INDmoney.

Final Word

If you applied for Gaudium IVF IPO, use PAN-based search first on Bigshare, and cross-check on NSE/BSE if needed. Subscription ended strong, but GMP cooled to zero, so it’s sensible to keep listing expectations measured and plan for multiple outcomes.

If you don’t get an allotment, it’s not a “rejection” of you as an investor; it’s just math in an oversubscribed book. Watch the listing, then decide calmly whether the business still looks worth owning at the market price.

For more IPOs, check INDmoney’s IPO tracker here.

Disclaimer

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Please be informed that merely opening a trading and demat account will not guarantee investment in securities in the IPO. Investors are requested to do their own independent research and due diligence before investing in an IPO. Please read the SEBI-prescribed Combined Risk Disclosure Document prior to investing. This post is for general information and awareness purposes only and is nowhere to be considered as advice, recommendation, or solicitation of an offer to buy or sell, or subscribe for securities. INDstocks is acting as a distributor for non-broking products/services such as IPO, Mutual Fund, and Mutual Fund SIP. These are not exchange-traded products. All disputes with respect to the distribution activity would not have access to the Exchange investor redressal forum or the Arbitration mechanism. INDstocks Private Limited (formerly known as INDmoney Private Limited) does not provide any portfolio management services, nor is it an investment adviser. Logos above are the property of respective trademark owners, and by displaying them, INDstocks has no right, title, or interest in them. SEBI Stock Broking Registration No: INZ000305337, Trading and Clearing Member of NSE (90267, M70042) and BSE, BSE StarMF (6779), SEBI Depository Participant Reg. No. IN-DP-690-2022, Depository Participant ID: CDSL 12095500, Research Analyst Registration No. INH000018948 BSE RA Enlistment No. 6428.